Shares of 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) are scheduled to reverse split before the market opens on Tuesday, December 17th. The 1-135 reverse split was announced on Friday, December 13th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, December 16th.
22nd Century Group Stock Performance
NASDAQ:XXII traded down $0.02 during mid-day trading on Friday, hitting $0.05. 41,891,944 shares of the company’s stock traded hands, compared to its average volume of 3,301,603. The firm has a market capitalization of $2.28 million, a price-to-earnings ratio of 0.00 and a beta of 1.50. The firm has a 50 day moving average of $0.11 and a two-hundred day moving average of $0.43. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. 22nd Century Group has a 12 month low of $0.04 and a 12 month high of $4.31.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. The company had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.
Analysts Set New Price Targets
Get Our Latest Analysis on 22nd Century Group
Institutional Investors Weigh In On 22nd Century Group
An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new stake in 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is currently owned by institutional investors.
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to Use the MarketBeat Dividend Calculator
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Stock Dividend Cuts Happen Are You Ready?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.